Skip to main content
Clinical Trials/JPRN-UMIN000029126
JPRN-UMIN000029126
Recruiting
Phase 2

A prospective study to evaluate the usefulness of thrombomodulin-alpha in patients with severe acute pancreatitis. - Thrombomodulin alpha for severe acute pancreatitis.

rTM for SAP study group0 sites10 target enrollmentSeptember 14, 2017

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Severe acute pancreatitis
Sponsor
rTM for SAP study group
Enrollment
10
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 14, 2017
End Date
July 31, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
rTM for SAP study group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with allergy for thrombomodulin alpha. Pregnant patients or patients who were suspected pregnancy. Patients whose informed consent could not be obtained. In case that doctors judged inappropriate for the entry.

Outcomes

Primary Outcomes

Not specified

Similar Trials